Updated CMS Local Coverage Determinations (LCD) for Continuous Glucose Monitors (CGMs)

Effective beginning on April 16, CMS has updated its local coverage determinations (LCD) for continuous glucose monitors (CGMs). These revisions for Medicare coverage of CGMs include removing the requirement that a patient receive three or more daily administrations of insulin or be on a continuous subcutaneous insulin infusion pump, removing the requirement that a beneficiary’s insulin treatment regimen require frequent adjustment by the beneficiary, and authorizing the required clinician visit prior to CGM coverage to be conducted via telehealth.

This announcement was originally published online by the AANP Government  Affairs Update.